SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amerise Biosciences - Quaterly Results

06 Nov 2025 Evaluate
The revenue slipped marginally during the September 2025 quarter. A decline of about Rs. 0.00 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2025 is Rs. -0.42 millions as compared to Net Loss of Rs. -0.33 millions of corresponding quarter ended September 2024 Operating profit Margin for the quarter ended September 2025 further decreased to -0.42% as compared to -0.33% of corresponding quarter ended September 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.64 0.00 0.00 1.88 0.36 422.22
Other Income 0.68 0.00 0.00 0.68 0.00 0.00 0.00 0.00 0.00
PBIDT -0.42 -0.33 27.27 -0.50 -0.82 -39.02 0.07 -1.46 -104.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.42 -0.33 27.27 -0.50 -0.82 -39.02 0.07 -1.46 -104.79
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.42 -0.33 27.27 -0.50 -0.82 -39.02 0.07 -1.46 -104.79
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.42 -0.33 27.27 -0.50 -0.82 -39.02 0.05 -1.46 -103.42
Equity 66.07 66.07 0.00 66.07 66.07 0.00 66.07 66.07 0.00
PBIDTM(%) 0.00 0.00 0.00 -78.13 0.00 0.00 3.72 -405.56 -100.92

Amerise Biosciences Share Price

0.70 -0.01 (-1.41%)
15-Jun-2026 11:36 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: